Cardiac Disease Epidemic Fuels The Growth Of The Arrhythmia Market: Strategic Insights Driving Arrhythmia Market Momentum in 2025

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Large Will the Arrhythmia Market Size By 2025?
The size of the arrhythmia market has witnessed robust growth in recent times. It is expected to expand from $7.8 billion in 2024 to $8.35 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%. This growth during the historical period is associated with a surge in lifestyle-related risk factors, an increase in cardiovascular diseases, advances in implantable devices, a global rise in cardiac surgeries, an escalating demand for remote monitoring, and ongoing research and development in antiarrhythmic drugs.

How Big Is the Arrhythmia Market Size Expected to Grow by 2029?
Expectations are high for the arrhythmia market size to experience robust growth in the coming years, with an estimated value of $11.83 billion in 2029 and a compound annual growth rate (CAGR) of 9.1%. The anticipated growth during this forecast period can be credited to the increasing awareness and education, tailored medicine strategies, the growth of electrophysiology labs, emphasis on early recognition and prevention, genetic testing for hereditary arrhythmias, and improvements in healthcare infrastructure. Key tendencies anticipated during this forecasted timeframe include progressions in cardiac monitoring technologies, the implementation of telehealth and remote patient surveillance, concentration on detecting and managing atrial fibrillation (AF), the use of implantable devices for arrhythmia management, innovative developments in ECG monitoring devices, and a regulatory focus on medical device approvals.

View the full report here:
https://www.thebusinessresearchcompany.com/report/arrhythmia-global-market-report

Which Key Market Drivers Powering Arrhythmia Market Expansion and Growth?
The escalating frequency of cardiac diseases and other heart-related issues are predicted to boost the arrhythmia market's expansion down the road. Cardiac disease or cardiovascular disease encompasses a range of conditions affecting the heart and blood vessels, from atherosclerosis and heart attacks to stroke and arrhythmia among others. A high prevalence of heart failure, atrial fibrillation, and other types of cardiovascular diseases can stem from both functional flaws, such as diastolic and systolic dysfunction, as well as electrical malfunctions, leading to the development of arrhythmias. To illustrate, the CDC (Centers for Disease Control and Prevention), a U.S. government agency, reported in October 2022 that there were an estimated 69.7k deaths and 80.5k heart attacks attributed to heart disease every year in the United States. [i] Hence, the escalating frequency of cardiac diseases and other heart-related conditions is fueling the advancement of the arrhythmia market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8018&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Arrhythmia Market?
The development of new treatment methods is a notable trend in the arrhythmia market. Big players in the sector are focusing on the development of novel therapies like cryoablation therapy, which is a groundbreaking treatment for patients with arrhythmias. For example, in August 2023, GE HealthCare, an American medical technology firm, introduced CardioVisio for Atrial Fibrillation. This tool is a digital, patient-focused clinical decision support device designed for precision care. CardioVisio uses advanced data analysis and patient perspectives to assist healthcare workers in comprehending and managing atrial fibrillation, a prevalent heart disorder. Through the provision of customized care plans and real-time data monitoring, it aims to improve the precision of treatment decisions and enhance patient outcomes, thereby leading to significant progress in cardiac care management.

What Are the Emerging Segments in the Arrhythmia Market?
The arrhythmia market covered in this report is segmented -

1) By Type: Supraventricular Tachycardias, Ventricular Arrhythmias, Bradyarrhythmias, Other Types
2) By Test Equipment: Electrocardiogram (ECG), Holter Monitor
3) By Hearth Blocks: First Degree Heart Block, Second Degree Heart Block, Third Degree Heart Block
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Supraventricular Tachycardias: Atrial Fibrillation, Atrial Flutter, Paroxysmal Supraventricular Tachycardia (PSVT)
2) By Ventricular Arrhythmias: Ventricular Fibrillation, Ventricular Tachycardia, Premature Ventricular Contractions (PVCs)
3) By Bradyarrhythmias: Sinus Bradycardia, Heart Block
4) By Other Types: Long QT Syndrome, Wolff-Parkinson-White Syndrome, Torsades de Pointes

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8018&type=smp

Who Are the Global Leaders in the Arrhythmia Market?
Major companies operating in the arrhythmia market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, AliveCor Inc., Biotronik SE & Co. KG, Biotricity Inc., GE Healthcare, Koninklijke Philips N.V., Nihon Kohden Corporation, Spacelabs Healthcare, Welch Allyn Inc., Mylan N.V., Lepu Medical Technology Co. Ltd., iRhythm Technologies Inc., BioTelemetry Inc., Fukuda Denshi Co. Ltd., Smart Solutions Technologies Inc., Biosense Webster Inc., Cardiac Science Corporation, CardioComm Solutions Inc., CardioNet LLC, NUUBO SMART SOLUTIONS S.L., Cardiva Medical Inc., Osypka AG, Johnson & Johnson Services Inc., Pfizer Inc, Teva Pharmaceutical Industries Ltd, Applied Cardiac Systems, Acutus Medical, EP Solutions SA

Which are the Top Profitable Regional Markets for the Arrhythmia Industry?
North America was the largest region in the arrhythmia market in 2024. The regions covered in the arrhythmia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8018

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.